GSK pledges $30bn US investment as UK’s pharma woes deepen
British pharmaceutical firm GSK has pledged to invest $30bn (£22bn) in research and manufacturing in the US over the next five years. Announced at the…
British pharmaceutical firm GSK has pledged to invest $30bn (£22bn) in research and manufacturing in the US over the next five years. Announced at the…